Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 053633/0794 | |
| Pages: | 8 |
| | Recorded: | 08/28/2020 | | |
Attorney Dkt #: | 7158-101682-02 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
01/03/2023
|
Application #:
|
16929342
|
Filing Dt:
|
07/15/2020
|
Publication #:
|
|
Pub Dt:
|
02/04/2021
| | | | |
Title:
|
FIBROBLAST GROWTH FACTOR 1 (FGF1) MUTANT PROTEINS THAT SELECTIVELY ACTIVATE FGFR1B TO REDUCE BLOOD GLUCOSE
|
|
Assignee
|
|
|
10010 N. TORREY PINES ROAD |
LA JOLLA, CALIFORNIA 92037-1002 |
|
Correspondence name and address
|
|
S.L. RYBAK PH.D, KLARQUIST SPARKMAN, LLP
|
|
121 SW SALMON STREET
|
|
ONE WORLD TRADE CENTER, SUITE 1600
|
|
PORTLAND, OR 97204-2988
|
Search Results as of:
06/21/2024 09:07 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|